PAA 2.50% 20.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-160

  1. 2,841 Posts.
    lightbulb Created with Sketch. 2891
    also we already know inhibition of mTor pathway is beneficial for AD sufferers. Just need to Test in the clinic.

    https://hotcopper.com.au/data/attachments/5970/5970317-1de9ad2f3f3d716f01c07687316fe920.jpg

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
0.005(2.50%)
Mkt cap ! $98.49M
Open High Low Value Volume
20.5¢ 20.5¢ 20.0¢ $40.68K 199.8K

Buyers (Bids)

No. Vol. Price($)
4 61550 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 461092 8
View Market Depth
Last trade - 12.20pm 27/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.